A single-center experience of post-transplant lymphomas involving the central nervous system with a review of current literature-Reference-Cited by-同舟云学术

A single-center experience of post-transplant lymphomas involving the central nervous system with a review of current literature

Published:2019-01-11 Issue:4 Volume:10 Page:437-448
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Velvet Anju John John¹,Bhutani Shiv²,Papachristos Stavros¹,Dwivedi Reena³,Picton Michael²,Augustine Titus¹⁴,Morton Muir²

Affiliation:

1. Department of Renal and Pancreas Transplantation, Division of Surgery, Manchester Royal Infirmary, Manchester University Hospitals NHS Foundation Trust, Manchester, UK

2. Department of Renal Medicine and Transplant Nephrology, Manchester Royal Infirmary, Manchester University Hospitals NHS Foundation Trust, Manchester, UK

3. Department of Radiology, Manchester Royal Infirmary, Manchester University Hospitals NHS Foundation Trust, Manchester, UK

4. Division of Diabetes, Endocrinology and Gastroenterology, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-transplant lymphoproliferative disorders following kidney transplantation: A literature review with updates on risk factors, prognostic indices, screening strategies, treatment and analysis of donor type;Transplantation Reviews;2024-04

2. Growth Transformation of B Cells by Epstein-Barr Virus Requires IMPDH2 Induction and Nucleolar Hypertrophy;Microbiology Spectrum;2023-08-17

3. Important Considerations in the Diagnosis and Management of Post-transplant Lymphoproliferative Disorder;Current Oncology Reports;2023-05-10

4. Successful Treatment of Central Nervous System Post-Transplant Lymphoproliferative Disease With a Reduced Dose of High-Dose Methotrexate;Cureus;2022-12-15

5. CAR T-cell Infusion Following Checkpoint Inhibition Can Induce Remission in Chemorefractory Post-transplant Lymphoproliferative Disorder of the CNS;HemaSphere;2022-06-17